Two simple, sensitive, and selective spectrophotometric methods for the determination of 5-(aminosulfonyl)-4-chloro-2-((2-furanylmethyl)amino)benzoic acid (furosemide, FUR) are described. The methods are based on acid hydrolysis of FUR to free primary aromatic amine and diazotization followed by coupling with N-1-napthylethylene diamine (NEDA) (method A) or 4,5-dihydroxynaphthalene-2,7-disulfonic acid (chromotropic acid, CTA) (method B). The colored reaction product can be measured spectrophotometrically at 520 nm (method A) or 500 nm (method B). Beer's law is obeyed over the ranges of 1.75-21.0 µg mL −1 and 2.5-30.0 µg mL −1 , for method A and method B, respectively. Apparent molar absorptivities and Sandell's sensitivities (in L mol
Introduction
Furosemide (FUR), chemically known as 5-(aminosulfonyl)-4-chloro-2-[(2-furanylmethyl)amino] benzoic acid ( Fig. 1) , is a potent diuretic. It is used to treat excessive fluid accumulation and swelling of the body caused by heart failure, cirrhosis, chronic kidney failure, and nephritic syndrome. The association of FUR and N-amidino-3,5-diamino-6-chloropyrazinecarboxamide hydrochloride (amiloride hydrochloride, AMU) furnishes a valuable natriuretic agent with a weaker kaliuretic effect, minimizing the risk of alkalosis in the treatment of refractory edema associated with hepatic cirrhosis or congestive heart failure (Martindale: The extra pharmacopoeia, 1989) . Owing to its extensive use as a powerful diuretic, FUR has long attracted the attention of many analysts. A variety of analytical methods for the determination of FUR in biological fluids and pharmaceutical samples have been proposed; the methods published in the nineties and up to 2007 have been reviewed by Espinosa Bosch et al. (2008) . Official methods for the determination of FUR in dosage forms are based on titrimetry (European Di- rectorate for the Quality of Medicines, 2001), spectrophotometry (The United States Pharmacopoeia, 2000) , and HPLC (The British Pharmacopoeia Commission, 2002) . Many techniques for the determination of FUR in pharmaceuticals or in biological matrix are available, they include UV spectrophotometry (Tescarollo Dias et al., 2005) , spectrofluorimetry (Llorent-Martínez et al., 2005; Ioannou et al., 1998; Semaan et al., 2008) , high performance liquid chromatography (HPLC) with UV detection (Jankowski et al., 1997) , HPLC with fluorescence detection (Gomez et al., 2005; Reeuwijk et al., 1992; Abou-Auda et al., 1998) , HPLC with amperometric detection (Guzmán et al., 2003) , HPLC-DAD (Semaan et al., 2005a) , LC-MS (Abdel-Hamid, 2000) , GC-MS (Ptáček et al., 1996) , micellar-LC (Carda-Broch et al., 2002) , ratiospectra derivative spectroscopy (Millership et al., 2005) , and diffuse reflectance spectroscopy (Gotardo et al., 2004) .
Some of these methods suffer from interference from the tablet matrix, whereas others are timeconsuming or require expensive equipment and are consequently not suitable for routine analysis, particularly in developing and under developed countries. From the above, the need for a fast, low-cost and selective method seems clearly apparent. Visible spectrophotometry continues to fulfill the above defined requirements. Quite a few visible spectrophotmetric methods (Živanović et al., 1990; Gölcü, 2006; Semaan et al., 2005b; Semaan & Cavalheiro, 2006; Basavaiah et al., 2005; Sevillano-Cabeza et al., 1997; Mishra et al., 1990; Shah et al., 2005; Sastry et al., 1988 Sastry et al., , 1989 Issopoulos, 1989) have been developed for the quantification of FUR in pharmaceuti- cals; however, they suffer from one or the other disadvantage such as critical optimum conditions, heating and/or extraction step, narrow linear dynamic range and/or low sensitivity and poor selectivity (Table 1) . In search of a method overcoming these shortcomings, a procedure, based on the diazotization of the FUR, reported by Shah et al. (2005) attracted our attention. Though the method seems sensitive (ε = 1.0 × 10 4 L mol −1 cm −1 ), it involves a heating step leading to a certain amount of inaccuracy and imprecision.
In this paper, two simple procedures based on diazotization of acid hydrolyzed FUR followed by coupling with either N-1-napthylethylene diamine or chromotropic acid in a sulfuric acid medium and not employing a heating step are proposed. The measured absorbance of the highly stable red/orange color is proportional to the concentration of hydrolyzed FUR and thus permits spectrophotometric determination of the drug in pure form and in pharmaceutical formulations. Usefulness of the method was enhanced by applying it to the analysis of FUR in spiked human urine sample.
Materials and methods
A Systronics model 106 digital spectrophotometer provided with 1-cm matched quartz cells was used for absorbance measurements.
All chemicals were of analytical reagent grade and distilled water was used to prepare solutions. Standard stock solution of 1000 µg mL −1 pharmaceutical grade FUR, certified to be 99.85 % pure, (Hoechest Morrison Roussel Ltd., India), was prepared by dissolving 100 mg of FUR in 0.1 M NaOH, and made up to 100 mL with the same base. It was further diluted to obtain the working concentrations of 70 µg mL −1 and 100 µg mL −1 FUR solutions with the same base for method A and method B, respectively. A 2.0 % sodium nitrite (Merck, India) solution was prepared by dissolving 2.0 g of the chemical in water and completed to 100 mL with the same solvent. A 5.0 % sulfamic acid (Lobachemie, India) solution was prepared by dissolving 5.0 g of the chemical in water and completed to 100 mL with the same solvent. Solutions (2.5 g L −1 ) of N-1-napthylethylene diamine (NEDA) (Merck, India) and chromotropic acid (CTA) (Merck, India) were separately prepared by dissolving 0.25 g of each of the chemicals in water and diluting them to the mark in two separate 100 mL standard flasks. A 10 M sulfuric acid was prepared by dilution of the appropriate volume of concentrated sulfuric acid (specific gravity = 1.84, specific molarity = 18.38) with water.
Method A: Different aliquots of the standard solution (0.25-3.00 mL, 70 µg mL −1 ) of pure FUR were transferred into a series of 10 mL calibrated flasks by means of a micro burette and the total volume was adjusted to 3.0 mL with 0.1 M NaOH. To each flask, 1 mL of a 2 % solution of sodium nitrite was added followed by 2 mL of 10 M sulfuric acid, the flasks were kept aside for 15 min with occasional shaking before adding 1 mL of 5 % sulfamic acid. The flasks were constantly shaken for 5 min before the addition of 1 mL of 2.5 g L −1 NEDA to each flask and the solutions were made up to the mark with water. The absorbance of each solution was measured at 520 nm against the reagent blank.
Method B: Into a series of 10 mL calibrated flasks, 0.25-3.00 mL of 100 µg mL −1 of pure FUR were added by means of a micro burette and the total volume was made up to 3.0 mL with 0.1 M NaOH. To each flask, 1 mL of a 2 % solution of sodium nitrite and 2 mL of 10 M H 2 SO 4 were added, the solutions were left for 15 min before adding 1 mL of 5 % sulfamic acid and the flasks were constantly shaken for 5 min. Finally, to each flask, 1 mL of 2.5 g L −1 solution of CTA was added and the flasks were kept aside for 15 min before measuring the absorbance at 500 nm against the reagent blank.
An aliquot of standard solution containing 2.5 mg of pure FUR was added to a 5 mL urine sample and mixed for 2 min in a 125 mL separating funnel. It was then extracted with 30 mL of diethyl ether after acidifying the solution with 5 mL of 1 M HCl, followed by the procedure introduced by Abou-Auda et al. (1998) . The ether layer was quantitatively transferred into a beaker containing anhydrous sodium sulfate, later decanted into a dried beaker, and evaporated to dryness on a water bath. The residue was reconstituted into a 25 mL standard flask with 0.1 M NaOH. An aliquot of the resulting solutions was analyzed using the procedures of method A and method B.
Twenty tablets, each containing FUR alone or in combination with AMU, were separately weighed and ground to a fine powder (and preserved separately in two amber-colored bottles). An amount of either powder equivalent to 10 mg of FUR was weighed into a 50 mL calibrated flask, 40 mL of 0.1 M NaOH were added and the mixture was shaken for 20 min; then the volume was made up to the mark with the same solvent, the mixture was mixed well and filtered using Whatman No. 42 filter paper. The filtrates equivalent to 200 µg mL −1 FUR were diluted appropriately with 0.1 M NaOH to 70 µg mL −1 and 100 µg mL
FUR concentrations for method A and method B, respectively, and a convenient aliquot was subjected to analysis using procedures of method A and method B.
Results and discussion
Diazotization employing coupling reactions is the most generally used method of assay for sulfonamide drugs containing a free aromatic amino group or yielding an aromatic amino group upon hydrolysis or reduction. To the best of our knowledge, this selective reaction was not extended for the determination of FUR. Though FUR does not contain a free primary aromatic amino group its formation in the subsequent diazotization and coupling reactions is proposed (Fig. 1) . The proposed reaction steps are similar to the diazotization procedure of succinyl-sulfathiazole and phthalylsulfathiazole (Higuchi & Brochmann-Hassan, 1997) after the generation of a free amino group upon hydrolysis of the acyl group.
Probable reaction pathway
After the addition of sodium nitrite and sulfuric acid to the FUR solution, a bright yellow product, stable for less than 5 min, is formed. This can be due to the nitrozation of the secondary amino group which was later displaced by the α-methylene proton. Since the reduction potential of nitrous acid is +1.00 V (Mendham et al., 2004) it may be the source of acyl moiety formation in the third step. In acid hydrolysis, a free amino group which undergoes diazotization at room temperature is generated. The resulting eletrophilic diazonium compound was coupled at the nucleophilic centre of NEDA or CTA forming thus a stable diazo coupled compound peaking at 520 nm or 500 nm (Fig. 2) . Unlike NEDA, CTA contains two symmetrical nucleophilic centers but the reaction stoichiometry studies reveal that it couples only at one position. Stoichiometry of the reaction was studied adopting the limiting logarithmic method (Rose, 1964) . Two straight lines were obtained by increasing the concentrations of CTA while keeping the concentration of FUR constant (Fig. 3a) or by increasing the concentrations of FUR while keeping the concentration of CTA constant (Fig. 3b) . Slopes of the two straight lines were 1.00 and 1.12. This means that the reaction proceeds in the mole ratio of 1.00 : 1.12, i.e. in a ratio of 1 : 1.
Optimization of reaction conditions
Adding a sodium nitrite solution to the sodium hydroxide solution of FUR before the addition of sulfuric acid is important because, in that order, no difficulty arises from the amine salt precipitating without first being diazotized. Diazotization of FUR is most favorable in a sulfuric acid medium, rather than in hydrochloric acid, and the optimum acid was found to be 2 mL of 10 M H 2 SO 4 in the total volume of 6 mL as shown in Fig. 4 . The effect of sodium nitrite was studied by keeping 1 mL of (5 %) sulfamic acid constant and varying the volume of the 2 % sodium ni- trite solution. From Fig. 5 it is clear that 1 mL of 2 % sodium nitrite was found optimum and, at the same time, from the corresponding blank reading, 1 mL of 5 % sulfamic acid sufficed to destroy the excess nitrous acid as indicated by the gradual increase in the blank absorbance (> 1.0 mL NaNO 2 ) due to the presence of undestroyed nitrous acid. As shown in Fig. 6 , the diazotization reaction is complete in 15 min at room temperature. Identical experimental conditions are appli- cable for both methods of the diazotization of FUR. While coupling of diazotized FUR with NEDA was found to be instantaneous, the coupling reaction with CTA required 15 min. The resulting coupled products were stable for more than 24 h.
Analytical data
Linear regression equations: Y = a + bX (where Y = absorbance of a 1-cm layer of solution; a = intercept; b = slope and X = concentration in µg mL −1 ), for methods A and B were obtained by the least squares method (n = 7) and are summarized in Table 2 together with the Beer's law range, molar absorptivity, correlation coefficient, variance, and confidence limits for slope and intercept. The limits of detection (LOD) and quantitation (LOQ) calculated according to the European Medicines Agency (2005) guidelines are also presented in Table 2 .
The significance of correlation coefficients in method A and method B was evaluated by calculating the tvalues using the following formula (Miller & Miller, 2000) :
The calculated t-values were compared with the tabulated values at the 95 % significance level using a two-sided t-test and (n − 2) degrees of freedom. The null hypothesis in this case was that there was no correlation between the measured absorbance (Y ) and the concentration (X ). Since the calculated t-values were 34.29 and 39.98 for method A and method B, respectively, both greater than the tabulated value (2.57), the null hypothesis was rejected and it was concluded that there is a significant correlation between Y and X. As expected, the closer |r| is to 1, i.e. as the straight-line relationship becomes stronger, the larger t values are obtained.
Method validation
Precision of the methods was calculated in terms of intermediate precision (intra-day and inter-day) (Shabir, 2003) . Three different concentrations of FUR 98.56 ± 1.08 (t = 2.01; F = 1.27) a) Geno Pharmaceuticals Ltd., Karaswada, Goa-403507; b) Aventis Pharma Ltd., Ankleshwar-393002; c) Elder Pharmaceuticals Pvt Ltd. Mumbai-400053. Tabulated t-value at the 95 % confidence level is 2.78; tabulated F-value at the 95 % confidence level is 6.39.
were analyzed in seven replicates during the same day (intra-day precision) for five consecutive days (interday precision). RSD (%) values of the intra-day and inter-day studies showed that the precision was good (Table 3) . Accuracy of an analytical method expresses the closeness between the reference and the found values. Accuracy was evaluated as percentage relative error between the measured concentrations and the concentrations taken for FUR (bias %). The results obtained are compiled in Table 3 and they show that the accuracy is good.
A study of potential interference in the present proposed methods was performed by selecting the excipients often used in pharmaceutical formulations or as possible co-active substances. Selectivity was evaluated by both placebo blank analysis and recovery studies. A placebo blank, the commonly employed tablet excipients, consisting of 20 mg of sodium alginate, 30 mg of magnesium stearate, 20 mg of lactose, 20 mg of acacia, 50 mg of talc, and 30 mg of starch, but without FUR, was prepared and analyzed as described above. The resulting absorbance readings for both the methods were the same as those for the reagent blank, and no interference from the placebo was observed. This was further confirmed by a recovery study from a synthetic mixture prepared by adding 10 mg of FUR to 50 mg of the placebo blank. The active component was extracted into 0.1 M NaOH as described above. The recoveries of FUR were (101.93 ± 1.63) % and (103.66 ± 0.76) % for method A and method B, respectively. Selectivity of the methods was thus confirmed.
Spiked urine sample and pharmaceutical formulations analysis
The proposed methods were successfully applied to the determination of FUR in spiked urine samples (Table 4) , two representative tablets, and one combination tablet; the results are summarized in Table 5 . The results obtained were statistically compared with those of The United States Pharmacopoeia (2000) method by applying the Students t-test for accuracy and the F-test for precision. The United States Pharmacopoeia (2000) method consists in the extraction of FUR from the matrices using 0.1 M NaOH and the detection at 271 nm. As can be seen from Table 5 , calculated t-value and F-value at the 95 % confidence level did not exceed the tabulated values of 2.77 and 6.39, respectively, for four degrees of freedom. The results indicate that there is no difference between the proposed methods and the reference method with respect to accuracy and precision. Pre-analyzed tablet powder containing FUR was spiked with pure FUR at three concentration levels and the total was found by the proposed methods. Each determination was done three times. The results of this study are compiled in Table 6 .
Conclusions
The proposed methods are known for the generation of free primary aromatic amine in one pot in a simple step using the same nitrous acid diazotizing the drug. The methods are selective as the free aromatic amine group formed preferentially interacts with nitrous acid to form the diazotized product which is later coupled with either NEDA or CTA to form very stable dye stuff. The results obtained show that the proposed methods can be useful in the determination of FUR in spiked human urine at the levels obtained after the administration of normal clinical doses in patients. The methods have also been successfully extended to the determination of FUR in commercial pharmaceutical preparations when present either alone or in combination with amiloride hydrochloride.
